The clinical relevance of these findings was verified through the detection of increases in both RET expression and GDNF-regulated transcriptional pathways in recurrent tumor samples (73.1%) compared to 55.8% of primary tumors, which was reproduced in analysis of the TCGA and NIH ROCK databases. This evidence concerns the gene RET and neoplasm.